165 related articles for article (PubMed ID: 38409613)
1. Opportunities for personalised follow-up in breast cancer: the gap between daily practice and recurrence risk.
Voets MM; Hassink NS; Veltman J; Slump CH; Koffijberg H; Siesling S
Breast Cancer Res Treat; 2024 Jun; 205(2):313-322. PubMed ID: 38409613
[TBL] [Abstract][Full Text] [Related]
2. Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients.
Witteveen A; Vliegen IM; Sonke GS; Klaase JM; IJzerman MJ; Siesling S
Breast Cancer Res Treat; 2015 Aug; 152(3):627-36. PubMed ID: 26162567
[TBL] [Abstract][Full Text] [Related]
3. Predicting the risk of locoregional recurrence after early breast cancer: an external validation of the Dutch INFLUENCE-nomogram with clinical cancer registry data from Germany.
Voelkel V; Draeger T; Groothuis-Oudshoorn CGM; de Munck L; Hueting T; Gerken M; Klinkhammer-Schalke M; Lavric M; Siesling S
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1823-1833. PubMed ID: 30927074
[TBL] [Abstract][Full Text] [Related]
4. Applying Risk-Based Follow-Up Strategies on the Dutch Breast Cancer Population: Consequences for Care and Costs.
Draeger T; Voelkel V; Groothuis-Oudshoorn CGM; Lavric M; Veltman J; Dassen A; Boersma LJ; Witteveen A; Sonke GS; Koffijberg H; Siesling S
Value Health; 2020 Sep; 23(9):1149-1156. PubMed ID: 32940232
[TBL] [Abstract][Full Text] [Related]
5. Risk-based breast cancer follow-up stratified by age.
Witteveen A; Otten JWM; Vliegen IMH; Siesling S; Timmer JB; IJzerman MJ
Cancer Med; 2018 Oct; 7(10):5291-5298. PubMed ID: 30207076
[TBL] [Abstract][Full Text] [Related]
6. Patterns and predictors of first and subsequent recurrence in women with early breast cancer.
Geurts YM; Witteveen A; Bretveld R; Poortmans PM; Sonke GS; Strobbe LJA; Siesling S
Breast Cancer Res Treat; 2017 Oct; 165(3):709-720. PubMed ID: 28677011
[TBL] [Abstract][Full Text] [Related]
7. Adherence to quality breast cancer survivorship care in four Canadian provinces: a CanIMPACT retrospective cohort study.
McBride ML; Groome PA; Decker K; Kendell C; Jiang L; Whitehead M; Li D; Grunfeld E;
BMC Cancer; 2019 Jul; 19(1):659. PubMed ID: 31272420
[TBL] [Abstract][Full Text] [Related]
8. Adherence to the Dutch Breast Cancer Guidelines for Surveillance in Breast Cancer Survivors: Real-World Data from a Pooled Multicenter Analysis.
Draeger T; Voelkel V; Schreuder K; Veltman J; Dassen A; Strobbe L; Heijmans HJ; Koelemij R; Groothuis-Oudshoorn CGM; Siesling S
Oncologist; 2022 Oct; 27(10):e766-e773. PubMed ID: 35962739
[TBL] [Abstract][Full Text] [Related]
9. Adherence to guidelines and breast cancer patients survival: a population-based cohort study analyzed with a causal inference approach.
Andreano A; Rebora P; Valsecchi MG; Russo AG
Breast Cancer Res Treat; 2017 Jul; 164(1):119-131. PubMed ID: 28365831
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01.
Yamashiro H; Iwata H; Masuda N; Yamamoto N; Nishimura R; Ohtani S; Sato N; Takahashi M; Kamio T; Yamazaki K; Saito T; Kato M; Lee T; Kuroi K; Takano T; Yasuno S; Morita S; Ohno S; Toi M;
Breast Cancer; 2020 Jul; 27(4):631-641. PubMed ID: 32060785
[TBL] [Abstract][Full Text] [Related]
11. A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making.
Pleijhuis RG; Kwast AB; Jansen L; de Vries J; Lanting R; Bart J; Wiggers T; van Dam GM; Siesling S
Breast; 2013 Oct; 22(5):773-9. PubMed ID: 23462681
[TBL] [Abstract][Full Text] [Related]
12. Adherence to Needed Adjuvant Therapy Could Decrease Recurrence Rates for Rural Patients With Early Breast Cancer.
Xuan Q; Gao K; Song Y; Zhao S; Dong L; Zhang Z; Zhang Q; Wang J
Clin Breast Cancer; 2016 Dec; 16(6):e165-e173. PubMed ID: 27544692
[TBL] [Abstract][Full Text] [Related]
13. Conditional regional recurrence risk: The effect of event-free years in different subtypes of breast cancer.
Vane MLG; Moossdorff M; van Maaren MC; van Kuijk SMJ; van Nijnatten TJA; van Roozendaal LM; Boerma EG; de WIlt JHW; Smidt ML
Eur J Surg Oncol; 2021 Jun; 47(6):1292-1298. PubMed ID: 33349525
[TBL] [Abstract][Full Text] [Related]
14. Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case-Control Study.
Collins LC; Achacoso N; Haque R; Nekhlyudov L; Quesenberry CP; Schnitt SJ; Habel LA; Fletcher SW
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S502-8. PubMed ID: 26059650
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the adherence to follow-up care guidelines for women with breast cancer.
Grandjean I; Kwast AB; de Vries H; Klaase J; Schoevers WJ; Siesling S
Eur J Oncol Nurs; 2012 Jul; 16(3):281-5. PubMed ID: 21816672
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the Age-Based Recommendations for Long-Term Follow-Up in Breast Cancer.
Witteveen A; de Munck L; Groothuis-Oudshoorn CGM; Sonke GS; Poortmans PM; Boersma LJ; Smidt ML; Vliegen IMH; IJzerman MJ; Siesling S
Oncologist; 2020 Sep; 25(9):e1330-e1338. PubMed ID: 32510767
[TBL] [Abstract][Full Text] [Related]
17. The Value of Ipsilateral Breast Tumor Recurrence as a Quality Indicator: Hospital Variation in the Netherlands.
van der Heiden-van der Loo M; Siesling S; Wouters MW; van Dalen T; Rutgers EJ; Peeters PH
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S522-8. PubMed ID: 25986872
[TBL] [Abstract][Full Text] [Related]
18. Follow-up strategies for women treated for early breast cancer.
Moschetti I; Cinquini M; Lambertini M; Levaggi A; Liberati A
Cochrane Database Syst Rev; 2016 May; 2016(5):CD001768. PubMed ID: 27230946
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Web-Based IBTR! 2.0 Nomogram to Predict for Ipsilateral Breast Tumor Recurrence After Breast-Conserving Therapy.
Kindts I; Laenen A; Peeters S; Janssen H; Depuydt T; Nevelsteen I; Van Limbergen E; Weltens C
Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1477-1484. PubMed ID: 27315662
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.
Yi M; Meric-Bernstam F; Kuerer HM; Mittendorf EA; Bedrosian I; Lucci A; Hwang RF; Crow JR; Luo S; Hunt KK
J Clin Oncol; 2012 Feb; 30(6):600-7. PubMed ID: 22253459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
